New
Pharmacology and the Nursing Process - Binder Ready,
Edition 11Editors: By Linda Lane Lilley, PhD, RN, Shelly Rainforth Collins, PharmD, BCGP and Julie S. Snyder, MSN, RN, MEDSURG-BC
Publication Date:
13 Feb 2026
Hazards
-
The publication contains no hazards
Conformance
-
PDF/UA-1
-
The publication contains a conformance statement that it meets the EPUB Accessibility 1.1, WCAG 2.1, Level AA standard. Please see https://bornaccessible.benetech.org/certified-publishers/ for further details of our compatibility testing.
-
The publication was certified on 20250728
-
Accessibility addendum
-
The certifier's credential is https://bornaccessible.benetech.org/certified-publishers/
-
For detailed accessibility information, see Elsevier’s website at https://www-elsevier-com.ucc.idm.oclc.org/about/accessibility
-
Compatibility tested
-
For queries regarding accessibility information, contact [email protected]
Ways Of Reading
-
This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation.
-
Short alternative textual descriptions
-
Information-rich images are described by extended descriptions
-
Visualised data also available as non-graphical data
-
All contents of the digital publication necessary to use and understanding, including any text, images (via alternative descriptions), video (via audio description) is fully accessible via suitable audio reproduction.
Navigation
-
The contents of the PDF have been tagged to permit access by assistive technologies as per PDF-UA-1 standard.
-
Index with links to referenced entries
-
Page breaks included from the original print source
-
Elements such as headings, tables, etc. for structured navigation
Additional Accessibility Information
-
All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
-
The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
-
For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
-
Content is enhanced with ARIA roles to optimize organization and facilitate navigation
-
Where interactive content is included in the product, controls are provided (e.g., for speed, pause and resume, reset) and labelled to make their use clear.
-
WCAG v2.2
Product Content
-
Content includes any type of illustrations.
-
The primary content is text.
-
Content includes a significant number of actionable (clickable) web links to external content, downloadable resources, supplementary material, etc.
-
Content includes a significant number of actionable (clickable) cross-references, hyperlinked notes and annotations, or with other actionable links between largely textual elements (e.g., quiz/test questions, ‘choose your own ending’, etc.).
-
Additional text not part of main content
-
Content includes photographs, whether in a plate section / insert or not.
-
Content includes figures, diagrams, charts and/or graphs, including other ‘mechanical’ (i.e. non-photographic) illustrations.
-
Content includes a significant number of web links (printed URLs, QR codes etc.).
-
Text within images
-
Content includes visual content that is purely decorative and is not necessary to understanding of the content.
-
At least some text – including text within other images – is ‘text as an image’ (i.e., a picture of text).
Note
-
This product relies on 3rd party tooling which may impact the accessibility features visible in inspection copies. All accessibility features mentioned would be present in the purchased version of the title.
Gain the pharmacology knowledge and skills you need to administer medications safely! Pharmacology and the Nursing Process, 11th Edition, provides practical, easy-to-use pharmacology information, emphasizing the application of the nursing process, the NCSBN Clinical Judgment Measurement Model, and prioritization throughout the book. Coverage begins with pharmacology basics, then discusses drugs by body systems and drug functions. Hundreds of full-color illustrations show how drugs work in the body and depict key steps in medication administration. Written by pharmacology experts Linda Lane Lilley, Shelly Rainforth Collins, and Julie S. Snyder, this bestselling textbook makes it easy to understand and apply pharmacology concepts and provide safe, quality nursing care.
Key Features
- ¿¿¿¿¿NEW! Updated drug content reflects the latest FDA drug approvals, withdrawals, and therapeutic uses
- NEW! The 6 cognitive skills of NCSBN’s Clinical Judgment Measurement Model (NCJMM) are now identified in headings along with the corresponding steps of the nursing process
- NEW! Integration of International Classification of Nursing Practice (ICNP) nursing diagnoses facilitates interprofessional collaboration with standardized terminology
- UPDATED! Culture content reflects a greater sensitivity to issues of cultural humility and fosters patient-centered care
- The Nursing Process is applied to each category of drugs, and includes the steps of assessment, diagnosis, planning, implementation, and evaluation
- Consistent presentation for each drug group includes mechanism of action, indications, contraindications, adverse effects, interactions, and dosages, ending with drug profiles of individual drugs in the class or group
- UNIQUE! Photo Atlas of Drug Administration features more than 100 drawings and photographs showing drug administration techniques
- UNIQUE! Key drug approach focuses on need-to-know drug content and related nursing care for the drugs that nurses will most commonly encounter in clinical practice
- Emphasis on drug classes describes key similarities and differences among the drugs in each class, making it easier for you to understand how individual drugs work in the body and to incorporate new drug information into your knowledge base as new drugs are approved
- High-alert drug icons identify medications that pose a greater risk to patient safety
- Focus on prioritization includes prioritized patient problems, along with a corresponding prioritization of goals and outcomes, to help you learn to connect patient problems with goals and outcomes of drug therapy
- Practical focus on medication safety includes discussions of what nurses may encounter during drug administration in a variety of health care settings, providing accounts of real-life medication errors and tips for avoiding those errors
- Ease of readability makes pharmacology content more understandable
- Dosages tables summarize generic and trade names, pharmacologic classes, normal dosage ranges, and indications for drugs
- Focus on quality and safety includes case studies that feature collaboration and teamwork content, as well as Preventing Medication Errors boxes
- Learning features at the beginning of each chapter include objectives and key terms
- Learning features at the end of each chapter include key points, clinical judgment exercises, and review questions
New Features
- UPDATED! Content reflects the latest FDA drug approvals and therapeutic uses
- NEW! The 6 cognitive skills of NCSBN’s Clinical Judgment Measurement Model (CJMM) are now identified in headings along with the corresponding steps of the nursing process
- NEW! Integration of International Classification of Nursing Practice (ICNP) nursing diagnoses instead of the less-widely-used Human Needs Statements
- UPDATED! Culture content reflects a greater sensitivity to issues of cultural humility, diversity, and inclusion
- NEW! Enhanced emphasis on nursing self-care and health equity (including new Social Determinants of Health boxes) reflects greater alignment with the 2021 AACN Essentials and the 2020-2030 Future of Nursing report
- NEW! Clinical judgment exercises are now incorporated into the textbook for enhanced preparation for the Next-Generation NCLEX® Exam (NGN)
- EXPANDED! Additional NGN-style questions are now provided on the Evolve companion website
About the author
By Linda Lane Lilley, PhD, RN, Associate Professor Emeritus, School of Nursing, Old Dominion University, Virginia Beach, Virginia, USA; Shelly Rainforth Collins, PharmD, BCGP, President, Drug Information Consultants, Chesapeake, Virginia, USA and Julie S. Snyder, MSN, RN, MEDSURG-BC, Adjunct Faculty, School of Nursing, Old Dominion University, Virginia Beach, Virginia, USA
PART 1 Pharmacology Basics
1. The Nursing Process and Drug Therapy
2. Pharmacologic Principles
3. Lifespan Considerations
4. Cultural, Legal, and Ethical Considerations
5. Medication Errors: Preventing and Responding
6. Patient Education and Drug Therapy
7. Over-the-Counter Drugs and Herbal and Dietary Supplements
8. Gene Therapy and Pharmacogenomics
9. Photo Atlas of Drug Administration
PART 2 Drugs Affecting the Central Nervous System
10. Analgesic Drugs
11. General and Local Anesthetics
12. Central Nervous System Depressants and Muscle Relaxants
13. Central Nervous System Stimulants, Antimigraine Drugs, and Related Drugs
14. Antiepileptic Drugs
15. Antiparkinson Drugs
16. Psychotherapeutic Drugs
17. Substance Use Disorder
PART 3 Drugs Affecting the Autonomic Nervous System
18. Adrenergic Drugs
19. Adrenergic-Blocking Drugs
20. Cholinergic Drugs
21. Cholinergic-Blocking Drugs
PART 4 Drugs Affecting the Cardiovascular and Renal Systems
22. Antihypertensive Drugs
23. Antianginal Drugs
24. Heart Failure Drugs
25. Antidysrhythmic Drugs
26. Coagulation Modifier Drugs
27. Antilipemic Drugs
28. Diuretic Drugs
29. Fluids and Electrolytes
PART 5 Drugs Affecting the Endocrine and Reproductive Systems
30. Pituitary Drugs
31. Thyroid and Antithyroid Drugs
32. Diabetes Drugs
33. Adrenal Drugs
34. Women’s Health Drugs
35. Men’s Health Drugs
PART 6 Drugs Affecting the Respiratory System
36. Antihistamines, Decongestants, Antitussives, and Expectorants
37. Respiratory Drugs
PART 7 Antiinfective and Antiinflammatory Drugs
38. Antibiotics Part 1
39. Antibiotics Part 2
40. Antiviral Drugs
41. Antitubercular Drugs
42. Antifungal Drugs
43. Antimalarial, Antiprotozoal, and Anthelmintic Drugs
44. Antiinflammatory and Antigout Drugs
PART 8 Chemotherapeutic Drugs and Biologic and Immune Modifiers
45. Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs
46. Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and Miscellaneous Drugs
47. Biologic Response–Modifying and Antirheumatic Drugs
48. Immunosuppressant Drugs
49. Immunizing Drugs
PART 9 Drugs Affecting the Gastrointestinal System and Nutrition
50. Acid-Controlling Drugs
51. Bowel Disorder Drugs
52. Antiemetic and Antinausea Drugs
53. Vitamins and Minerals
54. Anemia Drugs
55. Nutritional Supplements
PART 10 Dermatologic, Ophthalmic, and Otic Drugs
56. Dermatologic Drugs
57. Ophthalmic Drugs
58. Otic Drugs
1. The Nursing Process and Drug Therapy
2. Pharmacologic Principles
3. Lifespan Considerations
4. Cultural, Legal, and Ethical Considerations
5. Medication Errors: Preventing and Responding
6. Patient Education and Drug Therapy
7. Over-the-Counter Drugs and Herbal and Dietary Supplements
8. Gene Therapy and Pharmacogenomics
9. Photo Atlas of Drug Administration
PART 2 Drugs Affecting the Central Nervous System
10. Analgesic Drugs
11. General and Local Anesthetics
12. Central Nervous System Depressants and Muscle Relaxants
13. Central Nervous System Stimulants, Antimigraine Drugs, and Related Drugs
14. Antiepileptic Drugs
15. Antiparkinson Drugs
16. Psychotherapeutic Drugs
17. Substance Use Disorder
PART 3 Drugs Affecting the Autonomic Nervous System
18. Adrenergic Drugs
19. Adrenergic-Blocking Drugs
20. Cholinergic Drugs
21. Cholinergic-Blocking Drugs
PART 4 Drugs Affecting the Cardiovascular and Renal Systems
22. Antihypertensive Drugs
23. Antianginal Drugs
24. Heart Failure Drugs
25. Antidysrhythmic Drugs
26. Coagulation Modifier Drugs
27. Antilipemic Drugs
28. Diuretic Drugs
29. Fluids and Electrolytes
PART 5 Drugs Affecting the Endocrine and Reproductive Systems
30. Pituitary Drugs
31. Thyroid and Antithyroid Drugs
32. Diabetes Drugs
33. Adrenal Drugs
34. Women’s Health Drugs
35. Men’s Health Drugs
PART 6 Drugs Affecting the Respiratory System
36. Antihistamines, Decongestants, Antitussives, and Expectorants
37. Respiratory Drugs
PART 7 Antiinfective and Antiinflammatory Drugs
38. Antibiotics Part 1
39. Antibiotics Part 2
40. Antiviral Drugs
41. Antitubercular Drugs
42. Antifungal Drugs
43. Antimalarial, Antiprotozoal, and Anthelmintic Drugs
44. Antiinflammatory and Antigout Drugs
PART 8 Chemotherapeutic Drugs and Biologic and Immune Modifiers
45. Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs
46. Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and Miscellaneous Drugs
47. Biologic Response–Modifying and Antirheumatic Drugs
48. Immunosuppressant Drugs
49. Immunizing Drugs
PART 9 Drugs Affecting the Gastrointestinal System and Nutrition
50. Acid-Controlling Drugs
51. Bowel Disorder Drugs
52. Antiemetic and Antinausea Drugs
53. Vitamins and Minerals
54. Anemia Drugs
55. Nutritional Supplements
PART 10 Dermatologic, Ophthalmic, and Otic Drugs
56. Dermatologic Drugs
57. Ophthalmic Drugs
58. Otic Drugs
ISBN:
9780443121906
Page Count:
0
Retail Price
:
Nursing students in baccalaureate and associate degree programs